<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>Orforglipron on What is a GLP-1 Patch? | Comprehensive Guide &amp; Insights</title>
		<link>https://5485.22887.cc/tags/orforglipron/</link>
		<description>Recent content in Orforglipron on What is a GLP-1 Patch? | Comprehensive Guide &amp; Insights</description>
		<generator>Hugo</generator>
		<language>en-US</language>
		
		
		
		
			<lastBuildDate>Fri, 17 Oct 2025 10:25:14 -0500</lastBuildDate>
		
			<atom:link href="https://5485.22887.cc/tags/orforglipron/index.xml" rel="self" type="application/rss+xml" />
			<item>
				<title>What Is Orforglipron: The Oral GLP-1 That Skips the Injections</title>
				<link>https://5485.22887.cc/posts/what-is-orforglipron-the-oral-glp-1-that-skips-the-injection/</link>
				<pubDate>Fri, 17 Oct 2025 10:25:14 -0500</pubDate>
				<guid>https://5485.22887.cc/posts/what-is-orforglipron-the-oral-glp-1-that-skips-the-injection/</guid>
				<description>&lt;p&gt;Orforglipron is the talk of every endocrine conference right now—and for good reason. It&amp;rsquo;s an oral GLP-1 receptor agonist that doesn&amp;rsquo;t belong to the peptide class like semaglutide or tirzepatide. Instead, it&amp;rsquo;s a small molecule designed by Eli Lilly that hits the same GLP-1 receptor but survives the stomach&amp;rsquo;s acids without needing injection. I&amp;rsquo;ve been tracking this compound since phase 1, and the real question patients keep asking me is simple: what is orforglipron, and should I ditch my weekly shot for a daily pill? Let&amp;rsquo;s dig into the actual science.&lt;/p&gt;</description>
			</item>
	</channel>
</rss>
